Glutaric	_	B-Disease
acidemia	_	I-Disease
type	_	I-Disease
1.	_	O

Glutaric	_	O
acidemias	_	O
comprise	_	O
different	_	I-Disease
disorders	_	O
resulting	_	O
in	_	O
an	_	O
increased	_	O
urinary	_	O
excretion	_	O
of	_	O
glutaric	_	O
acid.	_	O
Glutaric	_	O
acidemia	_	O
type	_	I-Chemical
1	_	I-Chemical
(GA-1)	_	O
is	_	I-Disease
an	_	I-Disease
autosomal	_	I-Disease
recessive	_	O
disorder	_	O
of	_	I-Disease
lysine,	_	I-Disease
hydroxylysine,	_	I-Disease
and	_	O
tryptophan	_	O
metabolism	_	O
caused	_	O
by	_	I-Chemical
deficiency	_	O
of	_	O
glutaryl-CoA	_	O
dehydrogenase.	_	I-Disease
It	_	I-Disease
results	_	I-Disease
in	_	I-Disease
the	_	I-Disease
accumulation	_	O
of	_	O
3-hydroxyglutaric	_	O
and	_	O
glutaric	_	O
acid.	_	I-Chemical
Affected	_	I-Chemical
patients	_	I-Chemical
can	_	I-Chemical
present	_	O
with	_	O
brain	_	B-Species
atrophy	_	O
and	_	O
macrocephaly	_	O
and	_	I-Disease
with	_	I-Disease
acute	_	O
dystonia	_	I-Disease
secondary	_	O
to	_	O
striatal	_	O
degeneration	_	O
in	_	O
most	_	O
cases	_	I-Disease
triggered	_	I-Disease
by	_	O
an	_	O
intercurrent	_	O
childhood	_	O
infection	_	O
with	_	O
fever	_	O
between	_	O
6	_	I-Disease
and	_	I-Disease
18	_	O
months	_	O
of	_	O
age.	_	O
This	_	O
disorder	_	O
can	_	O
be	_	O
identified	_	O
by	_	O
increased	_	O
glutaryl	_	O
(C5DC)	_	O
carnitine	_	O
on	_	B-Chemical
newborn	_	O
screening.	_	O
Urine	_	O
organic	_	O
acid	_	O
analysis	_	O
indicates	_	O
the	_	I-Chemical
presence	_	O
of	_	O
excess	_	O
3-OH-glutaric	_	O
acid,	_	O
and	_	O
urine	_	O
acylcarnitine	_	I-Chemical
profile	_	O
shows	_	O
glutaryl	_	I-Chemical
carnitine	_	O
as	_	O
the	_	O
major	_	B-Chemical
peak.	_	I-Chemical
Therapy	_	O
consists	_	O
in	_	O
carnitine	_	O
supplementation	_	O
to	_	B-Chemical
remove	_	I-Chemical
glutaric	_	O
acid,	_	O
a	_	O
diet	_	O
restricted	_	O
in	_	I-Chemical
amino	_	O
acids	_	O
capable	_	O
of	_	O
producing	_	O
glutaric	_	O
acid,	_	O
and	_	O
prompt	_	O
treatment	_	B-Chemical
of	_	I-Chemical
intercurrent	_	O
illnesses.	_	O
Early	_	O
diagnosis	_	O
and	_	O
therapy	_	O
reduce	_	O
the	_	O
risk	_	O
of	_	O
acute	_	O
dystonia	_	O
in	_	O
patients	_	O
with	_	O
GA-1.	_	B-Disease

